Skip to content
Clinical Trials – home
AIO-Studien gGmbH
Sponsor

AIO-Studien gGmbH

Germany Kuno-Fischer-Strasse 8, Charlottenburg, 14057 Berlin, Germany

About the sponsor

The organisation demonstrates substantial engagement in advancing treatment strategies for digestive system malignancies. Research initiatives encompass comprehensive investigations into colorectal cancer, including both metastatic colorectal carcinoma and localised disease presentations. The sponsor supports studies examining peritoneal metastases and their surgical management through cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. Additional focus areas include gastric cancer and gastroesophageal junction tumours, with particular attention to locally advanced disease stages.

  • Colorectal Cancer Treatment Optimization
  • Peritoneal Surface Malignancies
  • Upper Gastrointestinal Tumours
  • Multimodal Therapy Approaches

Research programmes explore the integration of perioperative chemotherapy regimens and assess the role of neoadjuvant therapy in improving surgical outcomes and patient survival rates.

About Specializations

AIO-Studien gGmbH runs clinical trials in conditions such as Adenocarcinoma of colon, Colon cancer stage III, Non-small cell lung cancer, Lung neoplasm malignant, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

7 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:AIO-Studien gGmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BMS-986365
  • Sponsor:AIO-Studien gGmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tarlatamab
  • Sponsor:AIO-Studien gGmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Zimberelimab
  • Sponsor:AIO-Studien gGmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:AIO-Studien gGmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:AIO-Studien gGmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Osimertinib
  • Sponsor:AIO-Studien gGmbH

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.